Research graph
References from National trends in heart failure and hyperlipidemia related mortality in the United States, 1999–2024. Local targets link to admitted publications; unresolved targets remain external evidence.
Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023.
10.1016/j.jacc.2025.08.015 · 2025 · External reference
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.
10.1093/eurheartj/ehx144 · 2017 · External reference
Atherosclerosis.
10.1038/s41572-019-0106-z · 2019 · External reference
Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study.
10.1016/j.ehj.2004.06.038 · 2004 · External reference
Global burden of heart failure: a comprehensive and updated review of epidemiology.
10.1093/cvr/cvac013 · 2023 · External reference
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
2022 · External reference
Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis.
10.1186/s12944-019-1135-z · 2019 · External reference
Pleiotropic effects of statins on the cardiovascular system.
10.1161/circresaha.116.308537 · 2017 · External reference
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.
10.1093/eurheartj/ehz962 · 2020 · External reference
Heart Disease and stroke statistics-2023 update: a report from the American Heart Association.
10.1161/cir.0000000000001123 · 2023 · External reference
Transparency in the reporting of Artificial INtelligence – the TITAN guideline.
2025 · External reference
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
10.1016/j.jclinepi.2007.11.008 · 2008 · External reference
Rural-urban disparities: diabetes, hypertension, heart disease, and stroke mortality among black and white adults, 1999-2018.
10.1016/j.jacc.2021.01.032 · 2021 · External reference
Epidemiology of heart failure.
10.1161/circresaha.113.300268 · 2013 · External reference
Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.
10.1056/nejm199711063371906 · 1997 · External reference
Heterogeneous trends in burden of heart disease mortality by subtypes in the United States, 1999-2018: observational analysis of vital statistics.
10.1136/bmj.m2688 · 2020 · External reference
Heterogeneity in national U.S. mortality trends within heart disease subgroups, 2000-2015.
10.1186/s12872-017-0630-2 · 2017 · External reference
2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).
10.1001/jama.2013.284427 · 2014 · External reference
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
2018 · External reference
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).
10.1001/jama.285.19.2486 · 2001 · External reference
Changing cholesterol levels and coronary heart disease risk.
10.1161/circulationaha.115.020380 · 2016 · External reference
A comparative analysis of cardiovascular disease mortality trends attributable to risk factors in the United States and globally from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019.
10.1016/j.ajpc.2025.101064 · 2025 · External reference
The impact of the COVID-19 pandemic on mortality rates from non-communicable chronic diseases in Taiwan: an interventional time series study.
10.3389/ijph.2025.1607723 · 2025 · External reference
SARS-CoV-2 infection and cardiovascular disease: COVID-19 Heart.
10.1016/j.hlc.2020.05.101 · 2020 · External reference
Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes.
10.1161/circulationaha.110.968792 · 2011 · External reference
Hormones, genetic factors, and gender differences in cardiovascular disease.
10.1016/s0008-6363(01)00478-3 · 2002 · External reference
Endogenous sex hormones and cardiovascular disease in men.
10.1210/jc.2003-030611 · 2003 · External reference
Gender differences in cardiovascular disease and comorbid depression.
10.31887/dcns.2007.9.1/ammoeller · 2007 · External reference
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.
10.1016/s0140-6736(07)61778-4 · 2007 · External reference
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.
10.1161/hhf.0b013e318291329a · 2013 · External reference
Heart failure in hispanics.
10.1016/j.jacc.2008.12.037 · 2009 · External reference
Cardiovascular Health in African Americans: a scientific statement from the American Heart Association.
10.1161/cir.0000000000000534 · 2017 · External reference
Heart Disease and Stroke Statistics-2020 Update: a report from the American Heart Association.
10.1161/cir.0000000000000757 · 2020 · External reference
Care and outcomes of Hispanic patients admitted with heart failure with preserved or reduced ejection fraction: findings from get with the guidelines-heart failure.
10.1161/circheartfailure.111.963546 · 2012 · External reference
National Health and Nutrition Examination Survey 2017-March 2020 prepandemic data files-development of files and prevalence estimates for selected health outcomes.
2021 · External reference
Divergent temporal trends in morbidity and mortality related to heart failure and atrial fibrillation: age, sex, race, and geographic differences in the United States, 1991-2015.
10.1161/jaha.118.010756 · 2019 · External reference
Geographic variation in heart failure mortality and its association with hypertension, diabetes, and behavioral-related risk factors in 1,723 counties of the United States.
10.3389/fpubh.2018.00132 · 2018 · External reference
National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008.
10.1001/jama.2011.1474 · 2011 · External reference
Geographic variation in trends and disparities in heart failure mortality in the United States, 1999 to 2017.
10.1161/jaha.120.020541 · 2021 · External reference
Health, United States, 2001, With Urban and Rural Health Chartbook. National Center for Health Statistics (U.S.). DHHS publication (PHS)01-1232.
2001 · External reference
National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008.
10.1001/jama.2011.1474 · ExternalCitation · doi-reference
2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).
10.1001/jama.2013.284427 · ExternalCitation · doi-reference
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).
10.1001/jama.285.19.2486 · ExternalCitation · doi-reference
A comparative analysis of cardiovascular disease mortality trends attributable to risk factors in the United States and globally from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019.
10.1016/j.ajpc.2025.101064 · ExternalCitation · doi-reference
Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study.
10.1016/j.ehj.2004.06.038 · ExternalCitation · doi-reference
SARS-CoV-2 infection and cardiovascular disease: COVID-19 Heart.
10.1016/j.hlc.2020.05.101 · ExternalCitation · doi-reference
Heart failure in hispanics.
10.1016/j.jacc.2008.12.037 · ExternalCitation · doi-reference
Rural-urban disparities: diabetes, hypertension, heart disease, and stroke mortality among black and white adults, 1999-2018.
10.1016/j.jacc.2021.01.032 · ExternalCitation · doi-reference
Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023.
10.1016/j.jacc.2025.08.015 · ExternalCitation · doi-reference
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
10.1016/j.jclinepi.2007.11.008 · ExternalCitation · doi-reference
Hormones, genetic factors, and gender differences in cardiovascular disease.
10.1016/s0008-6363(01)00478-3 · ExternalCitation · doi-reference
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.
10.1016/s0140-6736(07)61778-4 · ExternalCitation · doi-reference
Atherosclerosis.
10.1038/s41572-019-0106-z · ExternalCitation · doi-reference
Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.
10.1056/nejm199711063371906 · ExternalCitation · doi-reference
Global burden of heart failure: a comprehensive and updated review of epidemiology.
10.1093/cvr/cvac013 · ExternalCitation · doi-reference
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.
10.1093/eurheartj/ehx144 · ExternalCitation · doi-reference
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.
10.1093/eurheartj/ehz962 · ExternalCitation · doi-reference
Heterogeneous trends in burden of heart disease mortality by subtypes in the United States, 1999-2018: observational analysis of vital statistics.
10.1136/bmj.m2688 · ExternalCitation · doi-reference
Cardiovascular Health in African Americans: a scientific statement from the American Heart Association.
10.1161/cir.0000000000000534 · ExternalCitation · doi-reference
Heart Disease and Stroke Statistics-2020 Update: a report from the American Heart Association.
10.1161/cir.0000000000000757 · ExternalCitation · doi-reference
Heart Disease and stroke statistics-2023 update: a report from the American Heart Association.
10.1161/cir.0000000000001123 · ExternalCitation · doi-reference
Care and outcomes of Hispanic patients admitted with heart failure with preserved or reduced ejection fraction: findings from get with the guidelines-heart failure.
10.1161/circheartfailure.111.963546 · ExternalCitation · doi-reference
Epidemiology of heart failure.
10.1161/circresaha.113.300268 · ExternalCitation · doi-reference
Pleiotropic effects of statins on the cardiovascular system.
10.1161/circresaha.116.308537 · ExternalCitation · doi-reference
Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes.
10.1161/circulationaha.110.968792 · ExternalCitation · doi-reference
Changing cholesterol levels and coronary heart disease risk.
10.1161/circulationaha.115.020380 · ExternalCitation · doi-reference
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.
10.1161/hhf.0b013e318291329a · ExternalCitation · doi-reference
Divergent temporal trends in morbidity and mortality related to heart failure and atrial fibrillation: age, sex, race, and geographic differences in the United States, 1991-2015.
10.1161/jaha.118.010756 · ExternalCitation · doi-reference
Geographic variation in trends and disparities in heart failure mortality in the United States, 1999 to 2017.
10.1161/jaha.120.020541 · ExternalCitation · doi-reference
Heterogeneity in national U.S. mortality trends within heart disease subgroups, 2000-2015.
10.1186/s12872-017-0630-2 · ExternalCitation · doi-reference
Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis.
10.1186/s12944-019-1135-z · ExternalCitation · doi-reference
Endogenous sex hormones and cardiovascular disease in men.
10.1210/jc.2003-030611 · ExternalCitation · doi-reference
Gender differences in cardiovascular disease and comorbid depression.
10.31887/dcns.2007.9.1/ammoeller · ExternalCitation · doi-reference
Geographic variation in heart failure mortality and its association with hypertension, diabetes, and behavioral-related risk factors in 1,723 counties of the United States.
10.3389/fpubh.2018.00132 · ExternalCitation · doi-reference
The impact of the COVID-19 pandemic on mortality rates from non-communicable chronic diseases in Taiwan: an interventional time series study.
10.3389/ijph.2025.1607723 · ExternalCitation · doi-reference
